|
|
Volumn 2, Issue 4, 2003, Pages 164-170
|
|
New therapies on the horizon for hepatitis C.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
ANTIVIRUS AGENT;
DNA DIRECTED RNA POLYMERASE;
MONOCLONAL ANTIBODY;
RECOMBINANT VACCINE;
RIBAVIRIN;
RIBOZYME;
VIRUS RNA;
DRUG ANTAGONISM;
FORECASTING;
GENE SILENCING;
GENETICS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
METABOLISM;
REVIEW;
VIROLOGY;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
DNA-DIRECTED RNA POLYMERASES;
FORECASTING;
GENE SILENCING;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
OLIGONUCLEOTIDES, ANTISENSE;
RIBAVIRIN;
RNA, CATALYTIC;
RNA, VIRAL;
VACCINES, SYNTHETIC;
MLCS;
MLOWN;
|
|
EID: 3042622806
PISSN: 16652681
EISSN: None
Source Type: Journal
DOI: 10.1016/s1665-2681(19)32128-3 Document Type: Review |
|
Times cited : (8)
|
|
References (24)
|
